These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 20431078)

  • 21. Early recovery and functional outcome are related with causal stroke subtype: data from the tinzaparin in acute ischemic stroke trial.
    Sprigg N; Gray LJ; Bath PM; Lindenstrøm E; Boysen G; De Deyn PP; Friis P; Leys D; Marttila R; Olsson JE; O'Neill D; Ringelstein EB; van der Sande JJ; Turpie AG;
    J Stroke Cerebrovasc Dis; 2007; 16(4):180-4. PubMed ID: 17689415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Symptomatic steno-occlusion of cerebral arteries and subsequent ischemic events in patients with acute ischemic stroke.
    Kang J; Kim N; Oh CW; Kwon OK; Jung CK; Kim WJ; Park JH; Ko Y; Noh WY; Jang MU; Hong JH; Lee JS; Lee J; Jang MS; Yang MH; Han MK; Bae HJ
    J Stroke Cerebrovasc Dis; 2014; 23(5):e347-53. PubMed ID: 24582792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Infarct pattern and clinical outcome in acute ischemic stroke following middle cerebral artery occlusion.
    Lee KJ; Jung KH; Byun JI; Kim JM; Roh JK
    Cerebrovasc Dis; 2014; 38(1):31-8. PubMed ID: 25196965
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Baseline National Institutes of Health stroke scale-adjusted time window for intravenous tissue-type plasminogen activator in acute ischemic stroke.
    Muchada M; Rubiera M; Rodriguez-Luna D; Pagola J; Flores A; Kallas J; Sanjuan E; Meler P; Alvarez-Sabin J; Ribo M; Molina CA
    Stroke; 2014 Apr; 45(4):1059-63. PubMed ID: 24603070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simple clinical predictors of stroke outcome based on National Institutes of Health Stroke scale score during 1-h recombinant tissue-type plasminogen activator infusion.
    Osaki M; Miyashita F; Koga M; Fukuda M; Shigehatake Y; Nagatsuka K; Minematsu K; Toyoda K
    Eur J Neurol; 2014 Mar; 21(3):411-8. PubMed ID: 24200315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pattern of response of National Institutes of Health Stroke Scale components to early recanalization in the CLOTBUST trial.
    Mikulik R; Dusek L; Hill MD; Fulep E; Grotta JC; Ribo M; Molina C; Alexandrov AV;
    Stroke; 2010 Mar; 41(3):466-70. PubMed ID: 20133918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Importance of cerebral artery recanalization in patients with stroke with and without neurological improvement after intravenous thrombolysis.
    Kharitonova TV; Melo TP; Andersen G; Egido JA; Castillo J; Wahlgren N;
    Stroke; 2013 Sep; 44(9):2513-8. PubMed ID: 23881960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carotid endarterectomy in the acute phase of stroke-in-evolution is safe and effective in selected patients.
    Leseche G; Alsac JM; Houbbalah R; Castier Y; Fady F; Mazighi M; Amarenco P
    J Vasc Surg; 2012 Mar; 55(3):701-7. PubMed ID: 22070936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Topographic patterns and stroke subtypes according to progressive motor deficits in lacunar syndrome.
    Kim YB; Moon HS; Suh BC; Park KY; Lee YT; Chung PW
    J Stroke Cerebrovasc Dis; 2011; 20(4):352-6. PubMed ID: 20656514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The association between hyperintense vessel sign and final ischemic lesion differ in its location.
    Kono T; Naka H; Nomura E; Hosomi N; Aoki S; Imamura E; Sueda Y; Nezu T; Mukai T; Ohshita T; Ohtsuki T; Wakabayashi S; Matsumoto M
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1337-43. PubMed ID: 24424335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Previous use of aspirin and baseline stroke severity: an analysis of 17,850 patients in the International Stroke Trial.
    Ricci S; Lewis S; Sandercock P;
    Stroke; 2006 Jul; 37(7):1737-40. PubMed ID: 16741185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
    Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
    Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in antiplatelet use prior to incident ischaemic stroke over 7 years in a UK centre and the association with stroke subtype.
    White JR; Bettencourt-Silva JH; Potter JF; Loke YK; Myint PK
    Age Ageing; 2013 Sep; 42(5):594-8. PubMed ID: 23832263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety of intravenous thrombolysis for acute ischemic stroke in patients receiving antiplatelet therapy at stroke onset.
    Diedler J; Ahmed N; Sykora M; Uyttenboogaart M; Overgaard K; Luijckx GJ; Soinne L; Ford GA; Lees KR; Wahlgren N; Ringleb P
    Stroke; 2010 Feb; 41(2):288-94. PubMed ID: 20056933
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rationale, design and baseline data of a randomized, double-blind, controlled trial comparing two antithrombotic regimens (a fixed-dose combination of extended-release dipyridamole plus ASA with clopidogrel) and telmisartan versus placebo in patients with strokes: the Prevention Regimen for Effectively Avoiding Second Strokes Trial (PRoFESS).
    Diener HC; Sacco R; Yusuf S; ;
    Cerebrovasc Dis; 2007; 23(5-6):368-80. PubMed ID: 17337887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delayed ischemic stroke after stent-assisted coil placement in cerebral aneurysm: characteristics and optimal duration of preventative dual antiplatelet therapy.
    Hwang G; Kim JG; Song KS; Lee YJ; Villavicencio JB; Suroto NS; Park NM; Park SJ; Jeong EA; Kwon OK
    Radiology; 2014 Oct; 273(1):194-201. PubMed ID: 24918960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of citicoline on ischemic lesions as measured by diffusion-weighted magnetic resonance imaging. Citicoline 010 Investigators.
    Warach S; Pettigrew LC; Dashe JF; Pullicino P; Lefkowitz DM; Sabounjian L; Harnett K; Schwiderski U; Gammans R
    Ann Neurol; 2000 Nov; 48(5):713-22. PubMed ID: 11079534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chinese medicine neuroaid efficacy on stroke recovery: a double-blind, placebo-controlled, randomized study.
    Chen CL; Young SH; Gan HH; Singh R; Lao AY; Baroque AC; Chang HM; Hiyadan JH; Chua CL; Advincula JM; Muengtaweepongsa S; Chan BP; de Silva HA; Towanabut S; Suwanwela NC; Poungvarin N; Chankrachang S; Wong KS; Eow GB; Navarro JC; Venketasubramanian N; Lee CF; Bousser MG;
    Stroke; 2013 Aug; 44(8):2093-100. PubMed ID: 23780952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High prevalence of previous antiplatelet drug use in patients with new or recurrent ischemic stroke: Buffalo metropolitan area and Erie County stroke study.
    Qureshi AI; Kirmani JF; Safdar A; Ahmed S; Sayed MA; Pande RU; Ferguson R; Hershey LA; Qazi KJ
    Pharmacotherapy; 2006 Apr; 26(4):493-8. PubMed ID: 16553507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dual antithrombotic therapy increases severe bleeding events in patients with stroke and cardiovascular disease: a prospective, multicenter, observational study.
    Toyoda K; Yasaka M; Iwade K; Nagata K; Koretsune Y; Sakamoto T; Uchiyama S; Gotoh J; Nagao T; Yamamoto M; Takahashi JC; Minematsu K;
    Stroke; 2008 Jun; 39(6):1740-5. PubMed ID: 18388341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.